Dialing Back M for Monoclonal: Successful De-escalation of Dose-Intensified Anti-tumor Necrosis Factor Therapy in Inflammatory Bowel Disease

Dialing Back M for Monoclonal: Successful De-escalation of Dose-Intensified Anti-tumor Necrosis Factor Therapy in Inflammatory Bowel Disease

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Digestive diseases and sciences 2022, Vol.67 (1), p.8-10
Hauptverfasser: Soo, Wei Ting, Costello, Samuel P., Bryant, Robert V.
Format: Artikel
Sprache:eng
Schlagworte:
Adalimumab
Biochemistry
Care and treatment
Editorial
Gastroenterology
Hepatology
Humans
Inflammatory Bowel Diseases - drug therapy
Medical colleges
Medicine
Medicine & Public Health
Necrosis
Oncology
Transplant Surgery
Tumor necrosis factor
Tumors
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 10
container_issue 1
container_start_page 8
container_title Digestive diseases and sciences
container_volume 67
creator Soo, Wei Ting
Costello, Samuel P.
Bryant, Robert V.
description
doi_str_mv 10.1007/s10620-021-06946-y
format Article
fullrecord <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_2505362755</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A706398702</galeid><sourcerecordid>A706398702</sourcerecordid><originalsourceid>FETCH-LOGICAL-c486t-7a857b3210048419f693af9aef9317ab36a69dc6fb412f7633ab1fc0637f2f983</originalsourceid><addsrcrecordid>eNp9ks9u1DAQxiMEokvhBTggS1y4uPhPYifctt0WVmrhQDlbE-94cUnsbZwI5R360HjZQgVCyAfb49_32TOeonjJ2QlnTL9NnCnBKBOcMtWUis6PigWvtKSiUvXjYsG4ymvO1VHxLKUbxlijuXpaHEmpldR1vSjuVh46H7bkFOw3ckVcHMhVDNF2MUD3jnyerMWU3NSRFVJMFjoYfQwkOrKKCek6jBiSdx43ZBlGT8epzx4f0Q4x-UQuwI55f_0VB9jNxAeyDq6Dvoccnslp_I7Z2ieEhM-LJw66hC_u5-Piy8X59dkHevnp_fpseUltWauRaqgr3UqRi1DWJW-caiS4BtA1kmtopQLVbKxybcmFy5lKaLmzLKfshGtqeVy8Ofjuhng7YRpN75PFroOAcUpGVKySSuiqyujrv9CbOA25NJlSXFeNYLV8oLbQofHBxXEAuzc1S53vbWrNRKZO_kHlscHe2xjQ-Rz_QyAOgn0t04DO7AbfwzAbzsy-BcyhBUxuAfOzBcycRa_uXzy1PW5-S379eQbkAUj5KGxxeEjpP7Y_ALGNu0k</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2617592083</pqid></control><display><type>article</type><title>Dialing Back M for Monoclonal: Successful De-escalation of Dose-Intensified Anti-tumor Necrosis Factor Therapy in Inflammatory Bowel Disease</title><source>MEDLINE</source><source>SpringerNature Journals</source><creator>Soo, Wei Ting ; Costello, Samuel P. ; Bryant, Robert V.</creator><creatorcontrib>Soo, Wei Ting ; Costello, Samuel P. ; Bryant, Robert V.</creatorcontrib><identifier>ISSN: 0163-2116</identifier><identifier>EISSN: 1573-2568</identifier><identifier>DOI: 10.1007/s10620-021-06946-y</identifier><identifier>PMID: 33763788</identifier><language>eng</language><publisher>New York: Springer US</publisher><subject>Adalimumab ; Biochemistry ; Care and treatment ; Editorial ; Gastroenterology ; Hepatology ; Humans ; Inflammatory Bowel Diseases - drug therapy ; Medical colleges ; Medicine ; Medicine &amp; Public Health ; Necrosis ; Oncology ; Transplant Surgery ; Tumor necrosis factor ; Tumors</subject><ispartof>Digestive diseases and sciences, 2022, Vol.67 (1), p.8-10</ispartof><rights>The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2021</rights><rights>COPYRIGHT 2022 Springer</rights><rights>The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2021.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c486t-7a857b3210048419f693af9aef9317ab36a69dc6fb412f7633ab1fc0637f2f983</citedby><cites>FETCH-LOGICAL-c486t-7a857b3210048419f693af9aef9317ab36a69dc6fb412f7633ab1fc0637f2f983</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s10620-021-06946-y$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s10620-021-06946-y$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,780,784,27924,27925,41488,42557,51319</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33763788$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Soo, Wei Ting</creatorcontrib><creatorcontrib>Costello, Samuel P.</creatorcontrib><creatorcontrib>Bryant, Robert V.</creatorcontrib><title>Dialing Back M for Monoclonal: Successful De-escalation of Dose-Intensified Anti-tumor Necrosis Factor Therapy in Inflammatory Bowel Disease</title><title>Digestive diseases and sciences</title><addtitle>Dig Dis Sci</addtitle><addtitle>Dig Dis Sci</addtitle><subject>Adalimumab</subject><subject>Biochemistry</subject><subject>Care and treatment</subject><subject>Editorial</subject><subject>Gastroenterology</subject><subject>Hepatology</subject><subject>Humans</subject><subject>Inflammatory Bowel Diseases - drug therapy</subject><subject>Medical colleges</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Necrosis</subject><subject>Oncology</subject><subject>Transplant Surgery</subject><subject>Tumor necrosis factor</subject><subject>Tumors</subject><issn>0163-2116</issn><issn>1573-2568</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNp9ks9u1DAQxiMEokvhBTggS1y4uPhPYifctt0WVmrhQDlbE-94cUnsbZwI5R360HjZQgVCyAfb49_32TOeonjJ2QlnTL9NnCnBKBOcMtWUis6PigWvtKSiUvXjYsG4ymvO1VHxLKUbxlijuXpaHEmpldR1vSjuVh46H7bkFOw3ckVcHMhVDNF2MUD3jnyerMWU3NSRFVJMFjoYfQwkOrKKCek6jBiSdx43ZBlGT8epzx4f0Q4x-UQuwI55f_0VB9jNxAeyDq6Dvoccnslp_I7Z2ieEhM-LJw66hC_u5-Piy8X59dkHevnp_fpseUltWauRaqgr3UqRi1DWJW-caiS4BtA1kmtopQLVbKxybcmFy5lKaLmzLKfshGtqeVy8Ofjuhng7YRpN75PFroOAcUpGVKySSuiqyujrv9CbOA25NJlSXFeNYLV8oLbQofHBxXEAuzc1S53vbWrNRKZO_kHlscHe2xjQ-Rz_QyAOgn0t04DO7AbfwzAbzsy-BcyhBUxuAfOzBcycRa_uXzy1PW5-S379eQbkAUj5KGxxeEjpP7Y_ALGNu0k</recordid><startdate>2022</startdate><enddate>2022</enddate><creator>Soo, Wei Ting</creator><creator>Costello, Samuel P.</creator><creator>Bryant, Robert V.</creator><general>Springer US</general><general>Springer</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9-</scope><scope>K9.</scope><scope>KB0</scope><scope>M0R</scope><scope>M0S</scope><scope>M1P</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope></search><sort><creationdate>2022</creationdate><title>Dialing Back M for Monoclonal: Successful De-escalation of Dose-Intensified Anti-tumor Necrosis Factor Therapy in Inflammatory Bowel Disease</title><author>Soo, Wei Ting ; Costello, Samuel P. ; Bryant, Robert V.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c486t-7a857b3210048419f693af9aef9317ab36a69dc6fb412f7633ab1fc0637f2f983</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Adalimumab</topic><topic>Biochemistry</topic><topic>Care and treatment</topic><topic>Editorial</topic><topic>Gastroenterology</topic><topic>Hepatology</topic><topic>Humans</topic><topic>Inflammatory Bowel Diseases - drug therapy</topic><topic>Medical colleges</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Necrosis</topic><topic>Oncology</topic><topic>Transplant Surgery</topic><topic>Tumor necrosis factor</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Soo, Wei Ting</creatorcontrib><creatorcontrib>Costello, Samuel P.</creatorcontrib><creatorcontrib>Bryant, Robert V.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>Consumer Health Database (Alumni Edition)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Consumer Health Database</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>Digestive diseases and sciences</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Soo, Wei Ting</au><au>Costello, Samuel P.</au><au>Bryant, Robert V.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Dialing Back M for Monoclonal: Successful De-escalation of Dose-Intensified Anti-tumor Necrosis Factor Therapy in Inflammatory Bowel Disease</atitle><jtitle>Digestive diseases and sciences</jtitle><stitle>Dig Dis Sci</stitle><addtitle>Dig Dis Sci</addtitle><date>2022</date><risdate>2022</risdate><volume>67</volume><issue>1</issue><spage>8</spage><epage>10</epage><pages>8-10</pages><issn>0163-2116</issn><eissn>1573-2568</eissn><cop>New York</cop><pub>Springer US</pub><pmid>33763788</pmid><doi>10.1007/s10620-021-06946-y</doi><tpages>3</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0163-2116
ispartof Digestive diseases and sciences, 2022, Vol.67 (1), p.8-10
issn 0163-2116
1573-2568
language eng
recordid cdi_proquest_miscellaneous_2505362755
source MEDLINE; SpringerNature Journals
subjects Adalimumab
Biochemistry
Care and treatment
Editorial
Gastroenterology
Hepatology
Humans
Inflammatory Bowel Diseases - drug therapy
Medical colleges
Medicine
Medicine & Public Health
Necrosis
Oncology
Transplant Surgery
Tumor necrosis factor
Tumors
title Dialing Back M for Monoclonal: Successful De-escalation of Dose-Intensified Anti-tumor Necrosis Factor Therapy in Inflammatory Bowel Disease
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-21T13%3A48%3A19IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Dialing%20Back%20M%20for%20Monoclonal:%20Successful%20De-escalation%20of%20Dose-Intensified%20Anti-tumor%20Necrosis%20Factor%20Therapy%20in%20Inflammatory%20Bowel%20Disease&rft.jtitle=Digestive%20diseases%20and%20sciences&rft.au=Soo,%20Wei%20Ting&rft.date=2022&rft.volume=67&rft.issue=1&rft.spage=8&rft.epage=10&rft.pages=8-10&rft.issn=0163-2116&rft.eissn=1573-2568&rft_id=info:doi/10.1007/s10620-021-06946-y&rft_dat=%3Cgale_proqu%3EA706398702%3C/gale_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2617592083&rft_id=info:pmid/33763788&rft_galeid=A706398702&rfr_iscdi=true